Taxifolin API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Taxifolin is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Taxifolin or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Taxifolin API 480-18-2?

Description:
Here you will find a list of producers, manufacturers and distributors of Taxifolin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Taxifolin 
Synonyms:
(+)-(2R,3R)-dihydroquercetin , (+)-dihydroquercetin , (+)-taxifolin , (2R,3R)-(+)-taxifolin , (2R,3R)-3,3',4',5,7-pentahydroxyflavanone , (2R,3R)-dihydroquercetin , Dihydroquercetin  
Cas Number:
480-18-2 
DrugBank number:
DB02224 
Unique Ingredient Identifier:
9SOB9E3987

General Description:

Taxifolin is a chemical compound identified by the CAS number 480-18-2. It is known for its distinct pharmacological properties and applications.

Classification:

Taxifolin belongs to the class of organic compounds known as flavanonols. These are compounds containing a flavan-3-one moiety, with a structure characterized by a 2-phenyl-3,4-dihydro-2H-1-benzopyran bearing a hydroxyl group and a ketone at the carbon C2 and C3, respectively, classified under the direct parent group Flavanonols. This compound is a part of the Organic compounds, falling under the Phenylpropanoids and polyketides superclass, and categorized within the Flavonoids class, specifically within the Flavans subclass.

Categories:

Taxifolin is categorized under the following therapeutic classes: Agents that produce hypertension, Analgesics, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Benzopyrans, Chromones, Flavonoids, Flavonols, Heterocyclic Compounds, Fused-Ring, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Pyrans, Sensory System Agents. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.

Experimental Properties:

Further physical and chemical characteristics of Taxifolin include:

  • logP: 0.95

Taxifolin is a type of Analgesics


Analgesics are a category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that are commonly used to relieve pain. They are designed to alleviate discomfort by targeting the body's pain receptors or by reducing inflammation. Analgesics are widely utilized in the medical field to manage various types of pain, ranging from mild to severe.

One of the primary classes of analgesics is nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs work by inhibiting the production of prostaglandins, substances that contribute to pain and inflammation. This class includes well-known drugs like ibuprofen and naproxen. Another class of analgesics is opioids, which are derived from opium or synthetic compounds that mimic the effects of opium. Opioids act on the central nervous system to reduce pain perception and provide potent pain relief. Examples of opioids include morphine, codeine, and oxycodone.

Analgesics are available in various forms, such as tablets, capsules, creams, and injections, allowing for different routes of administration based on the patient's needs. They are commonly used to manage pain associated with conditions like arthritis, headaches, dental procedures, and post-operative recovery.

It is important to note that analgesics should be used under medical supervision, as improper use or overuse can lead to adverse effects, including gastrointestinal complications, addiction, and respiratory depression in the case of opioids. Therefore, it is crucial for healthcare professionals to assess each patient's individual needs and prescribe the appropriate analgesic and dosage.

In summary, analgesics are a vital category of pharmaceutical APIs used to alleviate pain by targeting pain receptors or reducing inflammation. With various classes and forms available, they provide valuable options for pain management when used responsibly and under medical guidance.